News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Serious flaws in rare disorders medicine fund proposal


Serious flaws in rare disorders medicine fund proposal

Patient advocates are rallying support for submissions to Pharmac about the U-turn they have made on medicine funding for ultra-rare disorders. After repeated refusal to fund novel and expensive treatments for disorders that affect mostly just a handful of cases in New Zealand, Pharmac have announced a special $5 Million fund so they do get a chance of being funded here.

“That’s one great step forward”, says executive director of the NZ Organisation for Rare Disorders, John Forman, “but it is a long way from a serious solution to lack of access to these vital medicines”.

NZORD says the initial proposal from Pharmac suggested that the woefully inadequate budget was the major problem that would make it extremely difficult to get fair access across 7 diseases and estimated 85 patients needing treatment. “There needs to be $20 to $25 million per year invested in this area, rather than just $5 million, but we were still keen to work with Pharmac to try and ensure the most equitable distribution of the limited funds across these patient groups,” says Forman.

“However the formal consultation document shows serious flaws in the detail of the fund, which makes it even more unlikely that any of the patients will get a fair shot at treatment. These patients face triple-jeopardy in the way Pharmac has structured the criteria for the fund.”

“The first problem is the restrictive rules proposed by Pharmac, setting a higher efficacy threshold for these treatments for ultra-rare diseases, than is expected for medicines for common diseases. Secondly, Pharmac’s special committee for rare disorders has already signalled it will resist any acceptance of weaker evidence for them, even though this is invariably the case for such rare conditions. The third problem is how the paper makes it clear there will still be comparison of costs with medicines for common diseases, despite the obvious higher unit cost of development, and widespread acceptance in other jurisdictions that such treatments will not meet standard cost-effectiveness comparisons.” says Forman.

NZORD now suspects strongly that this system has been set up to fail, as reflected in the earlier assessment that the proposal was more likely a device to dampen debate over the election period, than a serious attempt to bring in an orphan drugs access programme.

NZORD is working with support groups for Muscular Dystrophy, Cystic Fibrosis, Lysosomal diseases, and Paroxysmal Nocturnal Haemoglobinuria, in an attempt to obtain subsidy of 8 new medicines for about 85 NZ patients who are currently left untreated.

Submissions on Pharmac’s consultation document close on Friday 25th July.


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Review: A Rose By Any Other Name Would Smell As Sweet

The Royal New Zealand Ballet has accepted the challenge of this heart-touching tragedy and largely succeeded. More>>

ALSO:

NZ's First Male IAAF Gold: Tom Walsh's Historic Shot Put Victory

Although feeling very sore but with a great feeling Tom Walsh took his place as number one on the victory dais to receive his much deserved gold medal. More>>

ALSO:

Scoop Review Of Books: Q&A: Hard To Find Books

"Unfortunately we are in crisis and this friendly dinosaur faces extinction… Our only hope is to try and raise funds to buy the building and restore it to its glory, either fully funded or with a viable deposit." More>>

Kid Lit: Lost Mansfield Story Discovered At Wellington Library

Previously undiscovered letters and a story written by a young Katherine Mansfield were recently unearthed in Wellington City Library’s archives by a local author researching a book about the famous writer. More>>

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION